Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.
Hashimoto
K
K
Sudo
T
T
Hirano
M
M
Motomura
H
H
Tagawa
K
K
Nashiro
S
S
Uemura
K
K
Yoshimoto
S
S
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003988:Dibenzothiepins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003988:Dibenzothiepins; C022172:zotepine